Xarelto Lawsuit Plaintiffs Use Results Of Study To Support Their Cases

June 09, 2016 – – TheProductLawyers.com reports on Xarelto, a blood thinner drug approved for use in 2011 by the U.S. Food and Drug Administration (FDA). Xarelto was released to the market to treat patients who may be at an increased risk of blood clots or stroke due to medical conditions such as atrial fibrillation, deep vein thrombosis, and pulmonary embolism or those who are recovering from surgeries for hip or knee replacements. The drug was hailed as a new-generation blood thinner, but it was soon after its release that the public began to hear about potentially dangerous side effects of the drug.

Upon hearing of possible dangerous side effects, medical professionals Judy Hun and John Hwang began to investigate the impact of the drug on their own patients. The doctors had noticed that some of their patients suffered from spontaneous bleeding in their eyes while taking Xarelto. They concluded from their study that the risk of eye bleeding may be increased for patients during the time when they are switching from a traditional blood thinner to Xarelto.

Another study was conducted from October 1st, 2010 to March 31st, 2012 that examined a large sample of patients across the United States who had taken various blood thinners such as Xarelto, Pradaxa, or Warfarin. It was found that of these 46,000 patients, there was a marked increase of gastrointestinal bleeding, as much as 50 percent, when Xarelto was used versus the use of Warfarin.

All of these studies have created serious concern over the drug’s alleged linkage to dangerous and spontaneous bleeding in patients. These concerns have prompted many lawsuits related to the drug, as well. Lawsuits number in excess of 2,800 cases in a federal multidistrict litigation (MDL 2592) overseen by the Honorable Judge Eldon Fallon of the Eastern District of Louisiana, as well as a mass tort program of an additional 550 cases in Philadelphia, PA.

The attorneys of Banville Law, the firm behind TheProductLawyers.com, are offering complimentary consultations to anyone who suffered injury or hospitalization after a bleed while on Xarelto. For more information about this release or the Xarelto litigation call 888-997-3792.

###

Contact TheProductLawyers.com:

Banville Law
888-997-3792
info@banvillelaw.com
165 West End Ave #1h,
New York, NY 10023

ReleaseID: 60010542